|
US6150328A
(en)
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
|
US6291206B1
(en)
|
1993-09-17 |
2001-09-18 |
Genetics Institute, Inc. |
BMP receptor proteins
|
|
EP0733109B9
(en)
|
1993-12-07 |
2006-07-05 |
Genetics Institute, LLC |
Bmp-12, bmp-13 and tendon-inducing compositions thereof
|
|
WO1999061044A1
(en)
*
|
1998-05-28 |
1999-12-02 |
The Board Of Trustees Of The University Of Arkansas |
Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
|
|
ES2639020T3
(es)
*
|
1998-11-27 |
2017-10-25 |
Ucb Pharma S.A. |
Composiciones y métodos para incrementar la mineralización de la substancia ósea
|
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
|
EP1223990B1
(en)
|
1999-10-15 |
2004-07-28 |
Genetics Institute, LLC |
Formulations of hyaluronic acid for delivery of osteogenic proteins
|
|
US7226587B2
(en)
|
2001-06-01 |
2007-06-05 |
Wyeth |
Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
|
|
WO2002099134A1
(en)
*
|
2001-06-05 |
2002-12-12 |
Auckland Uniservices Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
EP1399177A1
(en)
*
|
2001-06-08 |
2004-03-24 |
Smith & Nephew PLC |
Bmp binding proteins for use in bone or cartilage regeneration
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
GB2385052A
(en)
*
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
US20060276385A1
(en)
*
|
2003-01-13 |
2006-12-07 |
Hanjoong Jo |
Anti-inflammatory agents and methods of their use
|
|
EP1755648A2
(en)
*
|
2004-05-27 |
2007-02-28 |
Acceleron Pharma Inc. |
Cerberus/coco derivatives and uses thereof
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
EP1896607A4
(en)
*
|
2005-05-10 |
2009-12-16 |
Synergenz Bioscience Ltd |
METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE
|
|
JP2008545390A
(ja)
*
|
2005-05-19 |
2008-12-18 |
シナージェンズ バイオサイエンス リミティド |
遺伝的多型を用いた肺癌を発達させるリスクの評価方法
|
|
WO2006123954A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
WO2006123943A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
|
US20090298761A1
(en)
*
|
2006-05-17 |
2009-12-03 |
Donald Engelman |
Methods of treating cartilage defects using a soluble morphogenic protein complex
|
|
JP2010512326A
(ja)
*
|
2006-12-08 |
2010-04-22 |
アクセルロン ファーマ， インコーポレイテッド |
Ｃｅｒｂｅｒｕｓ、Ｃｏｃｏおよびこれらの誘導体の使用
|
|
CN105759056B
(zh)
*
|
2016-04-06 |
2017-11-14 |
四川大学华西医院 |
一种肺癌筛查试剂盒
|
|
US10961305B2
(en)
|
2016-12-21 |
2021-03-30 |
Mereo Biopharma 3 Limited |
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
|